ReviewCNS drugs2017
Lisdexamfetamine: A Review in Binge Eating Disorder.
Review in CNS drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and Safety of Lisdexamfetamine Versus Topiramate Versus Naltrexone/Bupropion in Individuals With Binge Eating Disorder: A Network Meta-Analysis.European eating disorders review : the journal of the Eating Disorders Association · 2026Pooled it
- Precision psychological markers enable targeted treatment in digital eating disorder interventions.medRxiv : the preprint server for health sciences · 2026Article
- Longitudinal analysis of decision-making deficits in binge-eating disorders using drift diffusion modeling.Appetite · 2026Article
- Translational Perspectives on Binge-Eating: Insights from Animal Models.Current psychiatry reports · 2026Review
- Anthropometric Trajectories and Dietary Compliance During a Personalized Ketogenic Program.Nutrients · 2025Article
- General Psychiatric Management for Adolescents With Borderline Personality Disorder and Eating Disorders.American journal of psychotherapy · 2025Review
- Effectiveness and predictors of weight loss response to phentermine plus lifestyle modifications among youth in a paediatric weight management clinical setting.Pediatric obesity · 2024Article
- An overview of the treatment of eating disorders in adults and adolescents: pharmacology and psychotherapy.Postepy psychiatrii neurologii · 2023Review
- Binge eating disorder.Nature reviews. Disease primers · 2022Article
- Article
- Taking the scenic route: an endogenous gut lipid messenger curbs binge eating in rats : A research highlight on 'Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge eating disorder' by Romano et al., 2020.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020Article
- Eating Disorders: An Evolutionary Psychoneuroimmunological Approach.Frontiers in psychology · 2019Article
- Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral lisdexamfetamine dimesylate (Vyvanse
Indexed as
Identifiers
29134566What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.